1 / 11

Overview

IP and access to HIV/AIDS Medicines in French speaking African countries: Issues, problems and prospects. Enga Kameni, Attorney and member, State Bar of New York and doctoral candidate, University of Pretoria, South Africa. World AIDS Conference, July 2012 Washington DC. Overview.

josiah
Télécharger la présentation

Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IP and access to HIV/AIDS Medicines in French speaking African countries: Issues, problems and prospects Enga Kameni, Attorney and member, State Bar of New York and doctoral candidate, University of Pretoria, South Africa. World AIDS Conference, July 2012 Washington DC

  2. Overview • General introduction to the francophone African speaking countries’ IP regime (OAPI) • HIV pandemic in the region • How IP is affecting access to medicines (including ARVs) in the OAPI Region • Which way forward

  3. Members of OAPI • Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Congo, Gabon, Guinea, Equatorial Guinea, Ivory Coast, Mauritania, Niger, Senegal, Togo

  4. State of HIV Pandemic in the OAPI Region • About 22 million people are currently living with HIV/AIDS in Africa

  5. Statistics of HIV-prevalence rates in OAPI Member States • 2.1million people about 10% of the total number of people living with HIV/AIDS in subSaharan Africa. • Benin:1.2%, Burkina Faso: 1.2%, Cameroon:5.3%, Central African Republic: 4.7%,Chad:3.4%, Congo: 3.4%, Gabon: 5.2%, Guinea: 1.3%, Guinea Bissau: 2.5%, Ivory Coast: 3.4%, Mali: 1.0%, Mauritania: 0.7%, Niger: 0.8%, Senegal: 0.9%, Togo: 3.2%

  6. Brief History of OAPI • Libreville Accord 1962 • Bangui Accord of 1977 • Revised Bangui Accord of 1999

  7. Current Problems • Patent term • No transition period for LDCs • Non-inclusion of the Doha Declaration • Regional exhaustion regime

  8. Potential problems • Bilateral trade treaties such as EPAs • Cameroon has concluded interim EPAs with the EU • Ivory Coast has concluded interim EPA with EU • Cotonou Agreement does not expressly provide for negotiation of IP in the EPA • Fears that EU might include them as they did with Cariforum

  9. Why the current/potential problems? • Internal factors • Nature of OAPI • Absence of strong and vocal NGOs • Local universities not very interested in IP • Absence of political will • External factors • Role of foreign powers France and the US • Role of WIPO

  10. Which way forward • Inclusion of TRIPS flexibilities • Human rights based approach • Civil society mobilization • Non-involvement of foreign powers and international organizations • Strengthening universities

  11. How? • Incorporation by reference • Direct application • Moratorium to LDCs

More Related